CoChat

Recovery of epinephrine response but not hypoglycemic symptom threshold after intensive therapy in type 1 diabetes

Davis, Maris, Mellman, Michael, Friedman, Seth, Chang, Chee Jen, Shamoon, Harry · 1994 · The American Journal of Medicine

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Abstract

Purpose Patients with intensively treated insulin-dependent diabetes mellitus (IDDM) exhibit more severe defects in counterregulatory hormone secretion and symptom recognition during hypoglycemia than do conventionally treated patients. In this prospective study in patients with preexisting defects in counterregulation, we examined the induction and reversibility of impaired symptomatic and adrenomedullary responses to hypoglycemia in 5 patients with IDDM (diabetes duration of 2 to 16 years; aged 19 to 36 years; 3 women, 2 men) who were receiving intensive therapy.Methods Counterregulatory responses were assessed by using a single-step (approximately 2.8 mmol/L plasma glucose) and multiple-step (from approximately 5 mmol/L to 2.2 mmol/L plasma glucose) clamped hypoglycemia procedure. Patients were first studied after a stable period of conventional insulin therapy (glycosylated hemoglobin [HbA1c] 9.5 +/- 1.2%), then after 3 to 5 months of intensive therapy (HbA1c 6.6 +/- 0.2%), and a third time after resuming conventional therapy (HbA1c 8.7 +/- 0.9%).Results Intensive therapy was associated with a 44% decline (P < 0.01) in the average plasma epinephrine increase during hypoglycemia, and the plasma glucose level required to stimulate epinephrine secretion fell from 3.7 +/- 0.2 to 3.0 +/- 0.1 mmol/L (P < 0.01). The threshold, but not the magnitude, of the plasma norepinephrine response was similarly altered. Hypoglycemic symptoms also decreased in intensity (by 67%, P < 0.01), and the glucose level required for symptom activation fell from 3.4 +/- 0.3 to 2.7 +/- 0.2 mmol/L, P < 0.01). When conventional therapy was resumed, the abnormalities in the epinephrine response due to intensive therapy were almost completely reversed. However, the reduction in symptoms and the altered thresholds for plasma norepinephrine were not reversed.Conclusions There is dissociation between the treatment-associated defects in hypoglycemia counterregulation in IDDM, and an increase in average glycemia produced by a return to conventional insulin therapy is not sufficient to reverse hypoglycemia unawareness worsened by intensive therapy.

Overview

Integrity signals

Registry

Crossref · 10.1016/0002-9343(94)90349-2

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 25 references

Cited by

See all 34

Metadata

Authors
Davis, M., Mellman, M., Friedman, S., Chang, C. J., & Shamoon, H.
Affiliations
Albert Einstein College of Medicine (US)
Venue
The American Journal of Medicine
Publisher
Elsevier BV
Published
1994-12
Volume
97
Issue
6
Pages
535-542
ISSN
0002-9343 (ISSN-L)
OpenAlex
W2081906000
Cited by
33
References
25
Citations by year
2023: 1 · 2018: 1 · 2017: 1 · 2016: 1 · 2015: 2 · 2013: 5 · 2012: 2
FWCI
0.59
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Locations
  • The American Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • American Diabetes Association
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK0700419, DK20541)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
Keywords
type 1 diabetes, intensive insulin therapy, hypoglycemia counterregulation, epinephrine response, hypoglycemic symptoms, norepinephrine, glycemic variability, conventional insulin therapy, HbA1c, autonomic dysfunction
MeSH terms
Adult, Diabetes Mellitus, Type 1, Epinephrine, Female, Humans, Hydrocortisone, Hypoglycemia, Insulin, Male, Norepinephrine, Prospective Studies, Growth Hormone

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Recovery of epinephrine response but not hypoglycemic symptom threshold after intensive therapy in type 1 diabetes. https://app.cochat.ai/papers/10.1016/0002-9343(94)90349-2
The paper
Davis, M., Mellman, M., Friedman, S., Chang, C. J., & Shamoon, H. (1994). Recovery of epinephrine response but not hypoglycemic symptom threshold after intensive therapy in type 1 diabetes. The American Journal of Medicine. https://doi.org/10.1016/0002-9343(94)90349-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.